Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series

OBJECTIVE: Treatment options for non-hospitalised patients with coronavirus disease 2019 (COVID-19) to reduce morbidity, mortality and spread of the disease are an urgent global need. The over-the-counter histamine-2 receptor antagonist famotidine is a putative therapy for COVID-19. We quantitively...

Descripción completa

Detalles Bibliográficos
Autores principales: Janowitz, Tobias, Gablenz, Eva, Pattinson, David, Wang, Timothy C, Conigliaro, Joseph, Tracey, Kevin, Tuveson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299656/
https://www.ncbi.nlm.nih.gov/pubmed/32499303
http://dx.doi.org/10.1136/gutjnl-2020-321852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299656/
https://www.ncbi.nlm.nih.gov/pubmed/32499303
http://dx.doi.org/10.1136/gutjnl-2020-321852

Ejemplares similares